Search the database for deliberate release of GM medicinal products
Displaying 1 - 1 of 1
| EU record number | Title | Company / Sponsor | Treated organism | Genetic modification |
|---|---|---|---|---|
| Only notified under the "contained use" procedure. Dossier submitted on . | A phase 2, open-label, multi-cohort, single-arm, multi-center trial to determine the safety, feasibility, and efficacy of JCAR015 in adult subjects with B-cell acute lymphoblastic leukemia | Celgene | Humans | Chimeric antigen receptor against CD19 |